Cite
MLA Citation
Brigitte Dreno et al.. “MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.” Lancet oncology, vol. 19, no. 7, 2018, pp. 916–929. http://access.bl.uk/ark:/81055/vdc_100066409248.0x00000d